(HealthDay News) — The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound. In a news release published Dec. 20, the FDA stated that Zepbound, part read more about This Weight Loss Drug Could Also Treat Sleep Apnea
(HealthDay News) — Genetic tests can show which patients with the blood cancer multiple myeloma should respond to targeted therapy, a new study finds. A special six-gene pattern can help predict who is more likely to respond well to Venclexta (venetoclax), read more about Do You Have the Right Genes for This Multiple Myeloma Treatment?
(HealthDay News) — Failing hearts nearly returned to full function in laboratory pigs after they received an experimental gene therapy. New research shows the gene therapy didn’t just prevent heart failure, a condition disproportionately affecting Black Americans, from worsening in four read more about This Heart Failure Gene Therapy May Be on It’s Way to Clinical Trials
(HealthDay News) — A newly approved immunotherapy can help adults with a difficult-to-treat form of leukemia, clinical trial results show. Aucatzyl (obecabtagene autoleucel) worked on more than three-quarters (76%) of patients with B-cell acute lymphoblastic leukemia (ALL), and more than half read more about This Clinical Trial Helped Hard-to-Treat Leukemia
